|Bid||261.19 x 1000|
|Ask||306.00 x 1300|
|Day's range||283.36 - 292.50|
|52-week range||205.10 - 305.21|
|Beta (5Y monthly)||0.74|
|PE ratio (TTM)||70.67|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||23 Nov 2012|
|1y target est||N/A|
Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The study findings show that monitoring with Masimo (MASI) SedLine Brain Function Monitoring parameters during CEA surgery can reduce the risk of postoperative delirium.
Abiomed's (ABMD) strength in Impella product revenues drives its Q2 top line.